​

Quince Therapeutics Ownership | Who Owns Quince Therapeutics?

OverviewForecastFinancialsChart

Quince Therapeutics Ownership Summary

Quince Therapeutics is owned by 0.27% institutional investors, 0.32% insiders, and 99.41% retail investors. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.93% of its assets in Quince Therapeutics shares.

QNCX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockQuince Therapeutics0.27%0.32%99.41%
SectorHealthcare Stocks 245.07%12.10%-157.17%
IndustryBiotech Stocks 380.48%11.73%-292.21%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202629-43.14%330,066-97.72%-19.34%15-40.00%138.33%
Mar 31, 202651-26.09%14,467,113-28.18%143.73%25-45.65%12140.00%
Dec 31, 20256950.00%20,143,30370.81%1177.67%46119.05%5-44.44%
Sep 30, 2025469.52%11,792,66355.60%-251.82%2116.67%9-
Jun 30, 20254210.53%7,578,81044.90%-339.82%1820.00%9-10.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv847.96K1.93%-
Vanguard Institutional Extnd Mkt Idx Tr12.04K1.18%1.00
iShares Micro-Cap ETF86.32K0.20%-
Bridgeway Ultra-Small Company Market55.00K0.13%-50.00K
Bridgeway Ultra-Small Company33.49K0.08%-
BlackRock Extended Equity Market K30.93K0.07%-13.00
Blackrock Extended Mkt Fund CF13.49K0.07%-
Extended Equity Market Fund E134.94K0.07%99.45K
Extended Equity Market Fund B134.94K0.07%99.45K
NT Ext Equity Mkt Idx Fd - L17.63K0.04%-

Recent Insider Transactions

DateNameRoleActivityValue
Dec 26, 2025Benatti Luca-Sell$173.50K
Aug 30, 2024Thye Dirk CEO AND CHIEF MEDICAL OFFICERBuy$53.90K
Aug 29, 2024Thye Dirk CEO AND CHIEF MEDICAL OFFICERBuy$53.48K
Aug 20, 2024Ryan Charles S. PRESIDENTBuy$31.45K
Aug 21, 2024Hannah Brendan CHIEF BUSINESS OFFICER AND COOBuy$3.10K

Insider Transactions Trends

DateBuySell
2026 Q1--
2025 Q4-1
2025 Q2--
2025 Q1--
2024 Q39-

QNCX Ownership FAQ

Who Owns Quince Therapeutics?

Quince Therapeutics shareholders are primarily institutional investors at 0.27%, followed by 0.32% insiders and 99.41% retail investors. The average institutional ownership in Quince Therapeutics's industry, Biotech Stocks , is 380.48%, which Quince Therapeutics falls below.

Does Blackrock own Quince Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Quince Therapeutics.

Who is the top mutual fund holder of Quince Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Quince Therapeutics shares, with 1.93% of its total shares outstanding invested in 847.96K Quince Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools